Tandem Diabetes Care Reports Fourth Quarter and Full Year 2013 Financial Results
Commercial sales of the t:slim Insulin Pump and related supplies commenced in August of 2012.
Neutral Tandem (TNDM) Announces Quarterly Earnings Results, Misses Estimates By $1.00 EPS
Neutral Tandem posted its quarterly earnings results on Thursday. The company reported earnings per share for the quarter, missing the consensus estimate of by $1.00, Stock Ratings Network.com reports.
Neutral Tandem Reaches New 12-Month High at $27.00
Neutral Tandem 's share price reached a new 52-week high on Monday, Analyst Ratings Net reports.
Neutral Tandem Now Covered by Deutsche Bank
The firm set a "hold" rating and a $26.00 price target on the stock. Deutsche Bank's price objective would suggest a potential upside of 4.88% from the stock's previous close.
NASDAQ Welcomes Tandem Diabetes Care (NASDAQ: TNDM) to The NASDAQ Stock Market
The NASDAQ OMX Group, Inc. announced today that trading of Tandem Diabetes Care, Inc. , a leading provider of insulin pump therapy, commenced on The NASDAQ Stock Market on November 14, 2013.